Since its foundation in 1997, Peptron Inc. has developed the fundamental technologies for peptide-based medicines. In line with proprietary technologies, we are developing sustained-release medications with a high technological entrance barrier and excellent product competitiveness, to treat life threatening and chronic diseases.
PeptrEXTM and SmartDepotTM, our two most representative technologies, help to transform the initi...
Since its foundation in 1997, Peptron Inc. has developed the fundamental technologies for peptide-based medicines. In line with proprietary technologies, we are developing sustained-release medications with a high technological entrance barrier and excellent product competitiveness, to treat life threatening and chronic diseases.
PeptrEXTM and SmartDepotTM, our two most representative technologies, help to transform the initial research process to the final medication development and successful commercialization phases.
During the 15 years of research and development process we accumulated extensive know-how.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.